NAGE
Niagen Bioscience Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$4.78
-0.04 ▼ -0.83%
🌙 3월 13일 7:46 PM ET (한국 3/14 08:46)
$4.77
-0.01 ▼ -0.29%
| Index | RUT | P/E | 23.37 | EPS (ttm) | 0.2 | Insider Own | 34.01% | Shs Outstand | 0.08B | Perf Week | -5.53% |
| Market Cap | 0.38B | Forward P/E | 13.86 | EPS next Y | 27.78% | Insider Trans | 0.02% | Shs Float | 0.05B | Perf Month | -6.46% |
| Enterprise Value | 0.32B | PEG | 0.37 | EPS next Q | 0.07 | Inst Own | 40.3% | Short Float | 12.22% | Perf Quarter | -27.36% |
| Income | 0.02B | P/S | 2.96 | EPS this Y | 35% | Inst Trans | 0.91% | Short Ratio | 5.68 | Perf Half Y | -50.31% |
| Sales | 0.13B | P/B | 4.98 | EPS next 5Y | 37.06% | ROA | 19.9% | Short Interest | 6.46M | Perf YTD | -24.84% |
| Book/sh | 0.96 | P/C | 5.91 | EPS past 3/5Y | - | ROE | 28.35% | 52W High | -67.46% ($14.69) | Perf Year | -38.08% |
| Cash/sh | 0.81 | P/FCF | 29.13 | Sales past 3/5Y | 21.56% 16.91% | ROIC | 22.19% | 52W Low | 1.16% ($4.72) | Perf 3Y | 198.75% |
| Dividend Est. | - | EV/EBITDA | 20.37 | EPS Y/Y TTM | 97.93% | Gross Margin | 64.28% | Volatility(W/M) | 6.15% 5.74% | Perf 5Y | -59.32% |
| Dividend TTM | - | EV/Sales | 2.48 | Sales Y/Y TTM | 29.95% | Oper. Margin | 11.05% | ATR (14) | 0.3 | Perf 10Y | 8.39% |
| Dividend Ex-Date | - | Quick Ratio | 3.83 | EPS Q/Q | -44.37% | Profit Margin | 13.43% | RSI (14) | 36.32 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 4.86 | Sales Q/Q | 16.19% | SMA20 | -5.03% ($5.03) | Beta | 2.22 | Target Price | $13.6 |
| Payout | - | Debt/Eq | 0.04 | Earnings | 3000000 | SMA50 | -14.96% ($5.62) | Rel Volume | 1.06 | Prev Close | $4.82 |
| Employees | 117 | LT Debt/Eq | 0.02 | EPS/Sales Surpr. | 127.27% 6.74% | SMA200 | -42.62% ($8.33) | Avg Volume(3M) | 1.14M | Price | $4.78 |
| IPO | 2008/6/24 | Option/Short | Yes/Yes | Trades | 7955 | Volume | 1,200,332 | Change | -0.83% |
뉴스 로딩 중...